No Data
[IPO Monthly Report] The hot market for Hong Kong IPOs in October remains unabated. The oversubscription ratio of Karotex was 1346 times, and China Resources Beverage may become the "capital freezing king" of the year.
In September, Midea Group Co., Ltd. (00300) raised 35.7 billion yuan, becoming the largest in the Hong Kong stock market since February 2021, the largest in Asia in the first three quarters of 2024, and the second largest in the world by 2024. The Chief Executive Officer of HKEX, Bonnie Chan Yi-Ting, stated: "Recently, the HKEX welcomed the largest in Asia and the second largest in the world in terms of new stock listings this year. Refinancing activities are also very active, demonstrating the depth and attractiveness of our market. The number of new stock listing applications further consolidates Hong Kong's position as the preferred new stock fundraising center in Asia. In addition, Alibaba has converted to a dual primary listing and was subsequently included in the Stock Connect."
Taimai Technology (02576): Stable pricing action, end of stable pricing period, and expiration of excess rights issue.
TaiMei Medical Technology (02576) announced that the stable price period for the global offering will expire on November 2, 2024...
HK Stocks Alert | UniMed Medical Technology (02576) plunges again by over 11%, the stock price almost halved after 5 days of listing. The company has accumulated losses of over 1.2 billion yuan in the past three years.
Shares of TaiMei Medical Technology (02576) have fallen by more than 11% again. Since its listing on October 8, the stock has been in a downturn for 5 trading days. The current stock price is close to half of the HK$13 IPO price.
"The first stock of medical saas", Taimei Medical Technology (2576.HK) went public, adding a new star to the digitalization track of life sciences.
Recently, many companies have submitted their applications in batches, and the IPO projects have also shown a significant acceleration, including high-quality investment symbols that the market has been eagerly anticipating. On October 8th, Tai Medi Technology, known as the first stock of medical SaaS (Software as a Service), officially went public. As the first Hong Kong stock to be listed after the National Day holiday, and with endorsements from star-studded institutions such as Hillhouse Capital and Tencent, Tai Medi Technology has attracted the attention of many investors. 1. Learning from the best: Tai Medi Technology, a company previously undervalued in the U.S. stock market, focuses on digital solutions in the field of life sciences, specifically in the medical and medical instruments industry, by designing and providing industry-specific solutions.
Zhejiang Taimei Medical Technology Opens 14% Lower in Hong Kong Trading Debut
New stock debut | TaiMei Medical Technology (02576) first listed, opened at a low of 13.54% in the morning.
Taimei Medical Technology (02576) is listed for the first time. The announcement shows a price of HK$13 per share, with a total issuance of 25.779 million shares, 200 shares per board lot. The net proceeds are expected to be approximately HK$0.2595 billion. As of the time of this report, it has dropped by 13.54%, trading at HK$11.24, with a turnover of HK$52.6929 million.
